Citadel Advisors »

GSK shares owned by Citadel Advisors

Quarter-by-quarter ownership of GSK (GSK) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $36M 972k 37.06
2023-09-30 $58M 1.6M 36.25
2023-06-30 $36M 1.0M 35.64
2023-03-31 $52M 1.4M 35.58
2022-12-31 $101M 2.9M 35.14

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
T. Rowe Price Associates
PRIMECAP Management Company
Royal Bank of Canada
Holocene Advisors
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
Provident Trust
Equity Investment Corp Acquisition
Hotchkis and Wiley Capital Management
Wells Fargo & Company
Hsbc Holdings
Douglas Lane & Associates

View all funds holding GSK